HomeSLP • NASDAQ
add
Simulations Plus Inc
Previous close
$31.82
Day range
$31.58 - $32.17
Year range
$27.12 - $51.22
Market cap
635.53M USD
Avg Volume
239.81K
P/E ratio
64.79
Dividend yield
0.76%
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | 18.66M | 19.42% |
Operating expense | 5.38M | -38.45% |
Net income | 843.00K | 57.87% |
Net profit margin | 4.52 | 32.16% |
Earnings per share | 0.06 | -66.67% |
EBITDA | 2.86M | -32.87% |
Effective tax rate | 2.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.26M | -82.46% |
Total assets | 196.64M | 5.66% |
Total liabilities | 14.21M | -11.60% |
Total equity | 182.43M | — |
Shares outstanding | 20.07M | — |
Price to book | 3.50 | — |
Return on assets | 1.86% | — |
Return on capital | 1.98% | — |
Cash Flow
Net change in cash
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | 843.00K | 57.87% |
Cash from operations | 1.66M | -45.62% |
Cash from investing | -99.50M | -19,234.62% |
Cash from financing | -945.00K | 20.45% |
Net change in cash | -98.78M | -4,229.64% |
Free cash flow | 2.23M | -65.43% |
About
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. Wikipedia
Founded
1996
Headquarters
Website
Employees
245
